Dexamethasone Suppresses Antigen-Induced Activation of Phosphatidylinositol 3-Kinase and Downstream Responses in Mast Cells

Journal of Immunology - Tập 172 Số 12 - Trang 7254-7262 - 2004
Marcus Vinícius Melo de Andrade1, Takaaki Hiragun2, Michael A. Beaven2
1Laboratory of Molecular Immunology, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD 20892 USA
2Laboratory of Molecular Immunology, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD 20892

Tóm tắt

Abstract Dexamethasone and other glucocorticoids suppress FcεRI-mediated release of inflammatory mediators from mast cells. Suppression of cytokine production is attributed to repression of cytokine gene transcription but no mechanism has been described for the suppression of degranulation. We show that therapeutic concentrations of dexamethasone inhibit intermediate signaling events, in particular the activation of phosphatidylinositol (PI)3-kinase and downstream signaling events that lead to degranulation in rat basophilic leukemia 2H3 cells. This inhibitory action is mediated via the glucocorticoid receptor and is not apparent when cells are stimulated via Kit in a mouse bone marrow-derived mast cell line. The primary perturbation appears to be the failure of the regulatory p85 subunit of PI3-kinase to engage with the adaptor protein Grb2-associated binder 2 leading to suppression of phosphorylation of phospholipase Cγ2, the calcium signal, and degranulation. Suppression of PI3-kinase activation by dexamethasone may also contribute to reduced cytokine production because the PI3-kinase inhibitor LY294002, like dexamethasone, inhibits Ag-induced transcription of cytokine genes as well as degranulation.

Từ khóa


Tài liệu tham khảo

Kawakami, T., S. J. Galli. 2002. Regulation of mast-cell and basophil function and survival by IgE. Nat. Rev. Immunol. 2:773.

Centers for Disease Control and Prevention.  1998. Forecasted state-specific estimates of self reported asthma prevalence: United States. MMWR Morb. Mortal. Wkly. Rep. 47:1022.

Robin, J. L., D. C. Seldin, K. F. Austen, R. A. Lewis. 1985. Regulation of mediator release from mouse bone marrow-derived mast cells by glucocorticoids. J. Immunol. 135:2719.

Collado-Escobar, D., J. R. Cunha-Melo, M. A. Beaven. 1990. Treatment with dexamethasone down-regulates IgE-receptor mediated signals and up-regulates adenosine-receptor mediated signals in a rat mast cell (RBL-2H3) line. J. Immunol. 144:244.

Rider, L. G., N. Hirasawa, F. Santini, M. A. Beaven. 1996. Activation of the mitogen-activated protein kinase cascade is suppressed by low concentrations of dexamethasone in mast cells. J. Immunol. 157:2374.

Wershil, B. K., G. T. Furuta, J. A. Lavigne, A. R. Choudhury, Z. S. Wang, S. J. Galli. 1995. Dexamethasone or cyclosporine A suppress mast cell-leukocyte cytokine cascades: multiple mechanisms of inhibition of IgE- and mast cell-dependent cutaneous inflammation in the mouse. J. Immunol. 154:1391.

Baumgartner, R. A., V. A. Deramo, M. A. Beaven. 1996. Constitutive and inducible mechanisms for synthesis and release of cytokines in immune cell lines. J. Immunol. 157:4087.

Fushimi, T., H. Okayama, S. Shimura, H. Saitoh, K. Shirato. 1998. Dexamethasone suppresses gene expression and production of IL-13 by human mast cell line and lung mast cells. J. Allergy Clin. Immunol. 102:134.

Sengoku, T., S. Kishi, S. Sakuma, Y. Ohkubo, T. Goto. 2000. FK506 inhibition of histamine release and cytokine production by mast cells and basophils. Int. J. Immunopharmacol. 22:189.

Krishnaswamy, G., T. Lakshman, A. R. Miller, S. Srikanth, K. Hall, S. K. Huang, J. Suttles, J. K. Smith, R. Stout. 1997. Multifunctional cytokine expression by human mast cells: regulation by T cell membrane contact and glucocorticoids. J. Interferon Cytokine Res. 17:167.

Ashwell, J. D., F. W. Lu, M. S. Vacchio. 2000. Glucocorticoids in T cell development and function. Annu. Rev. Immunol. 18:309.

Cancedda, C., G. Filaci, F. Puppo, M. Ghio, P. Contini, F. Indiveri. 2002. Immune homeostasis requires several biologic factors including glucocorticoid hormones. Ann. NY Acad. Sci. 966:49.

Irani, A. A., G. Nilsson, L. K. Ashman, L. B. Schwartz. 1995. Dexamethasone inhibits the development of mast cells from dispersed human fetal liver cells cultured in the presence of recombinant human stem cell factor. Immunology 84:72.

Smith, S. J., A. M. Piliponsky, F. Rosenhead, U. Elchalal, A. Nagler, F. Levi- Schaffer. 2002. Dexamethasone inhibits maturation, cytokine production and FcεRI expression of human cord blood-derived mast cells. Clin. Exp. Allergy 32:906.

Yamaguchi, M., K. Hirai, A. Komiya, M. Miyamasu, Y. Furumoto, R. Teshima, K. Ohta, Y. Morita, S. J. Galli, C. Ra, K. Yamamoto. 2001. Regulation of mouse mast cell surface FcεRI expression by dexamethasone. Int. Immunol. 13:843.

Adcock, I. M.. 2001. Glucocorticoid-regulated transcription factors. Pulmon. Pharmacol. Ther. 2001:211.

Van Laethem, F., E. Baus, F. Andris, J. Urbain, O. Leo. 2001. A novel aspect of the anti-inflammatory actions of glucocorticoids: inhibition of proximal steps of signaling cascades in lymphocytes. Cell Mol. Life Sci. 58:1599.

Collado-Escobar, D., H. Ali, M. A. Beaven. 1990. On the mechanism of action of dexamethasone in a rat mast cell line (RBL-2H3 cells): evidence for altered coupling of receptors and G-proteins. J. Immunol. 144:3449.

Rivera, J.. 2002. Molecular adapters in FcεRI signaling and the allergic response. Curr. Opin. Immunol. 14:688.

Saitoh, S., R. Arudchandran, T. S. Manetz, W. Zhang, C. L. Sommers, P. E. Love, J. Rivera, L. E. Samelson. 2000. LAT is essential for FcεRI-mediated mast cell activation. Immunity 12:525.

Gu, H., K. Saito, L. D. Klaman, J. Shen, T. Fleming, Y. Wang, J. C. Pratt, G. Lin, B. Lim, J. P. Kinet, B. G. Neel. 2001. Essential role for Gab2 in the allergic response. Nature 412:186.

Parravinci, V., M. Gadina, M. Kovarova, S. Odom, C. Gonzalez-Espinosa, Y. Furumoto, S. Saitoh, L. E. Samelson, J. J. O’Shea, J. Rivera. 2002. Fyn kinase initiates complementary signals required for IgE-dependent mast cell degranulation. Nat. Immunol. 3:741.

Koyasu, S.. 2003. The role of PI3K in immune cells. Nat. Immunol. 4:313.

Wyman, M. P., L. Pirola. 1998. Structure and function of phosphoinositide 3-kinases. Biochim. Biophys. Acta 1436:127.

von Willebrand, M., S. Williams, M. Saxena, J. Gilman, P. Tailor, T. Jascur, G. P. Amarante-Mendes, D. R. Green, T. Mustelin. 1998. Modification of phosphatidylinositol 3-kinase SH2 domain binding properties by Abl- or Lck-mediated tyrosine phosphorylation at Tyr-688. J. Biol. Chem. 273:3994.

Chan, T. O., U. Rodeck, A. M. Chan, A. C. Kimmelman, S. E. Rittenhouse, G. Panayotou, P. N. Tsichlis. 2002. Small GTPases and tyrosine kinases coregulate a molecular switch in the phosphoinositide 3-kinase regulatory subunit. Cancer Cells 1:181.

Cuevas, B. D., Y. Lu, M. Mao, J. Zhang, R. LaPushin, K. Siminovitch, G. B. Mills. 2001. Tyrosine phosphorylation of p85 relieves its inhibitory activity on phosphatidylinositol 3-kinase. J. Biol. Chem. 276:27455.

Cuevas, B., Y. Lu, S. Watt, R. Kumar, J. Zhang, K. A. Siminovitch, G. B. Mills. 1999. SHP-1 regulates Lck-induced phosphatidylinositol 3-kinase phosphorylation and activity. J. Biol. Chem. 274:27583.

Kovarova, M., P. Tolar, R. Arudchandran, L. Draberova, J. Rivera, P. Draber. 2001. Structure-function analysis of Lyn kinase association with lipid rafts and initiation of early signaling events after FcεRI aggregation. Mol. Cell Biol. 21:8318.

Hibbs, M. L., D. M. Tarlinton, J. Armes, D. Grail, G. Hodgson, R. Maglitto, S. A. Stacker, A. R. Dunn. 1995. Multiple defects in the immune system of Lyn-deficient mice, culminating in autoimmune disease. Cell 83:301.

Ali, H., J. R. Cunha-Melo, W. F. Saul, M. A. Beaven. 1990. The activation of phospholipase C via adenosine receptors provides synergistic signals for secretion in antigen stimulated RBL-2H3 cells: evidence for a novel adenosine receptor. J. Biol. Chem. 265:745.

Choi, W. S., Y. M. Kim, C. Combs, M. A. Frohman, M. A. Beaven. 2002. Phospholipase D1 and D2 regulate different phases of exocytosis in mast cells. J. Immunol. 168:5682.

Manetz, T. S., C. Gonzalez-Espinosa, R. Arudchandran, S. Xirasagar, V. Tybulewicz, J. Rivera. 2001. Vav1 regulates phospholipase Cγ activation and calcium responses in mast cells. Mol. Cell. Biol. 21:3763.

Benard, V., B. P. Bohl, G. M. Bokoch. 1999. Characterization of rac and cdc42 activation in chemoattractant-stimulated human neutrophils using a novel assay for active GTPases. J. Biol. Chem. 274:13198.

Pani, G., R. Colavitti, B. Bedogni, R. Anzevino, S. Borrello, T. Galeotti. 2000. A redox signaling mechanism for density-dependent inhibition of cell growth. J. Biol. Chem. 275:38891.

Petr, M. J., R. D. Wurster. 1997. Determination of in situ dissociation constant for fura-2 and quantitation of background fluorescence in astrocyte cell line U373-MG. Cell Calcium 21:233.

Grynkiewicz, G., M. Poenie, R. Y. Tsien. 1985. A new generation of Ca2+ indicators with greatly improved fluorescence properties. J. Biol. Chem. 260:3440.

Choi, O. H., J. H. Lee, T. Kassessinoff, J. R. Cunha-Melo, S. Jones, S. V., M. A. Beaven. 1993. Carbachol and antigen mobilize calcium by similar mechanisms in a transfected mast cell line (RBL-2H3 cells) that expresses M1 muscarinic receptors. J. Immunol. 151:5586.

Thomas, S. M., J. S. Brugge. 1997. Cellular functions regulated by Src family kinases. Annu. Rev. Cell. Dev. Biol. 13:513.

Yamashita, T., S. Y. Mao, H. Metzger. 1994. Aggregation of the high-affinity IgE receptor and enhanced activity of p53/56lyn protein-tyrosine kinase. Proc. Natl. Acad. Sci. USA 91:11251.

Faeder, J. R., W. S. Hlavacek, I. Reischl, M. L. Blinov, H. Metzger, A. Redondo, C. Wofsy, B. Goldstein. 2003. Investigation of early events in FcεRI-mediated signaling using a detailed mathematical model. J. Immunol. 170:3769.

Vivanco, I., C. L. Sawyers. 2002. The phosphatidylinositol 3-kinase AKT pathway in human cancer. Nat. Rev. Cancer 2:489.

Lu-Kuo, J. M., D. A. Fruman, D. M. Joyal, L. C. Cantley, H. R. Katz. 2000. Impaired Kit- but not Fcε-initiated mast cell acvtivation in the absence of phosphoinositide 3-kinase p85α gene products. J. Biol. Chem. 275:6022.

O’Sullivan, B. T., D. J. Cutler, G. E. Hunt, C. Walters, G. F. Johnson, I. A. Caterson. 1997. Pharmacokinetics of dexamethasone and its relationship to dexamethasone suppression test outcome in depressed patients and healthy control subjects. Biol. Psychiatry 41:574.

Nishida, K., L. Wang, E. Morii, S. J. Park, M. Narimatsu, S. Itoh, S. Yamasaki, M. Fujishima, K. Ishihara, M. Hibi, Y. Kitamura, T. Hirano. 2002. Requirement of Gab2 for mast cell development and KitL/c-Kit signaling. Blood 99:1866.

Serve, H., N. S. Yee, G. Stella, L. Sepp-Lorenzino, J. C. Tan, P. Besmer. 1995. Differential roles of PI3-kinase and Kit tyrosine 821 in Kit receptor-mediated proliferation, survival and cell adhesion in mast cells. EMBO J. 14:473.

Blume-Jensen, P., R. Janknecht, T. Hunter. 1998. The Kit receptor promotes cell survival via activation of PI 3-kinase and subsequent Akt-mediated phosphorylation of Bad on Ser-136. Curr. Biol. 8:779.

Linnekin, D.. 1999. Early signaling pathways activated by c-Kit in hematopoietic cells. Int. J. Biochem. Cell Biol. 31:1053.

Tkaczyk, C., M. A. Beaven, S. M. Brachman, D. D. Metcalfe, A. M. Gilfillan. 2003. The phospholipase Cγ1-dependent pathway of FcεRI-mediated mast cell activation is regulated independently of phosphatidylinositol 3-kinase. J. Biol. Chem. 278:48474.

Wen, R., S. T. Jou, Y. Chen, A. Hoffmeyer, D. Wang. 2002. Phospholipase Cγ2 is essential for specific functions of FcεR and FcγR. J. Immunol. 169:6743.

Barker, S. A., K. K. Caldwell, J. R. Pfeiffer, B. S. Wilson. 1998. Wortmannin-sensitive phosphorylation, translocation, and activation of PLCγ1, but not PLCγ2, in antigen-stimulated RBL-2H3 mast cells. Mol. Biol. Cell 9:483.

Choi, O. H., J. H. Kim, J. P. Kinet. 1996. Calcium mobilization via the sphingosine kinase in signalling by the FcεRI antigen receptor. Nature 380:634.

Mathes, C., A. Fleig, R. Penner. 1998. Calcium release-activated calcium current (ICRAC) is a direct target for sphingosine. J. Biol. Chem. 273:25020.

Melendez, A. J., A. K. Khaw. 2002. Dichotomy of Ca2+ signals triggered by different phospholipid pathways in antigen stimulation of human mast cells. J. Biol. Chem. 277:17255.

Yano, H., S. Nakanishi, K. Kimura, N. Hanai, Y. Saitoh, Y. Fukui, Y. Nonomura, Y. Matsuda. 1993. Inhibition of histamine secretion by wortmannin through the blockade of phosphatidylinositol 3-kinase in RBL-2H3 cells. J. Biol. Chem. 268:25846.

Barker, S. A., K. K. Caldwell, A. Hall, M. Martinez, J. R. Pfeiffer, J. M. Oliver, B. S. Wilson. 1995. Wortmannin blocks lipid and protein kinase activities associated with PI 3-kinase and inhibits a subset of responses induced by FcεR1 cross-linking. Mol. Biol. Cell 6:1145.

Barker, S. A., D. Lujan, B. S. Wilson. 1999. Multiple roles for PI 3-kinase in the regulation of PLCγ activity and Ca2+ mobilization in antigen-stimulated mast cells. J. Leukocyte Biol. 65:321.

Ishizuka, T., K. Chayama, K. Takeda, E. Hamelmann, N. Terada, G. M. Keller, G. L. Johnson, E. W. Gelfand. 1999. Mitogen-activated protein kinase activation through FcεRI and stem cell factor receptor is differentially regulated by phosphatidylinositol 3-kinase and calcineurin in mouse bone marrow-derived mast cells. J. Immunol. 162:2087.

Cissel, D. S., M. A. Beaven. 2000. Disruption of Raf-1/heat shock protein 90 complex and Raf signaling by dexamethasone in mast cells. J. Biol. Chem. 275:7066.

Van Laethem, F., X. Liang, F. Andris, J. Urbain, M. Vandenbranden, J. M. Ruysschaert, M. D. Resh, T. M. Stulnig, O. Leo. 2003. Glucocorticoids alter the lipid and protein composition of membrane rafts of a murine T cell hybridoma. J. Immunol. 170:2932.

Wilson, B. S., J. R. Pfeiffer, Z. Surviladze, E. A. Gaudet, J. M. Oliver. 2001. High resolution mapping of mast cell membranes reveals primary and secondary domains of FcεRI and LAT. J. Cell Biol. 154:645.

Zhang, C., R. A. Baumgartner, K. Yamada, M. A. Beaven. 1997. Mitogen activated protein (MAP) kinase regulates production of TNFα and release of arachidonic acid in mast cells: indications of communication between p38 and p42 MAP kinases. J. Biol. Chem. 272:13397.